Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
13- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----[1] 6 💬
2HYDROCORTISONE HYDROGEN SUCCINATE[3] Hydrocortisone,
Hydrocortisone succinate (Hydrocortisone hydrogen succinate),
Hydrogen		[2] Hydrocortisone ,
Hydrocortisone succinate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
3Hydrogen[1] Hydrogen---[6] 5, 6, 17, 83, 97, 226 💬
4Lisuride Hydrogenmaleate[1] Lisuride[1] Lisuride 💬 [3] DRD2,
DRD3,
DRD4 💬 		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
5Methylprednisolon-21-hydrogensuccinat, Natriumsalz[1] Methylprednisolone[1] Methylprednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
6TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)[1] Hydrogen---[1] 6 💬
7TERGURIDE HYDROGENMALEATE[1] Terguride[1] Terguride 💬 [2] DRD2,
PRL 💬 		[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 51 💬